Vanguard Amends 13G/A, Reports 0 Shares in AdaptHealth

AdaptHealth Corp Schedule 13G/A amendment: The Vanguard Group reports no beneficial ownership of AdaptHealth Corp common stock, listing 0 shares and 0% of the class.

Rhea-AI Filing Summary

AdaptHealth Corp Schedule 13G/A amendment: The Vanguard Group reports no beneficial ownership of AdaptHealth Corp common stock, listing 0 shares and 0% of the class. The filing explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report separately.

The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The disclosure states Vanguard entities retain the right to receive dividends or proceeds for managed accounts but that no single third party holds more than 5% of the class under the reported arrangement.

Insights

Institutional Ownership Specialist

Vanguard disaggregated holdings and reports zero beneficial ownership in this amendment.

The filing records an internal realignment dated January 12, 2026 and shows 0 shares and 0% beneficial ownership reported by The Vanguard Group for AdaptHealth Corp common stock. It notes that certain subsidiaries now report separately in reliance on SEC Release No. 34-39538.

Cash‑flow treatment and any prior holdings by disaggregated entities are not detailed in the excerpt; subsequent filings from the separate reporting entities would show any actual holdings.

Compliance & SEC Filings Analyst

The amendment documents compliance with the SEC disaggregation release and clarifies reporting structure.

The text cites SEC Release No. 34-39538 and states that certain subsidiaries ‘‘will report beneficial ownership separately.’b The signed amendment records the administrative change and reports no beneficial ownership by The Vanguard Group itself as of the filing.

Material implications depend on disclosures from those subsidiary filings; this amendment is administrative and does not by itself indicate a change in underlying economic ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AdaptHealth (AHCO) Schedule 13G/A amendment report?

It reports that The Vanguard Group beneficially owns 0 shares of AdaptHealth common stock, representing 0% of the class, and describes an internal reporting realignment dated January 12, 2026.

Why does Vanguard say subsidiaries will report separately for AHCO?

Vanguard cites SEC Release No. 34-39538 and an internal realignment on January 12, 2026, stating certain subsidiaries/business divisions will disaggregate and report beneficial ownership separately going forward.

Does this filing show any Vanguard entity holds more than 5% of AHCO?

No. The filing states no one other person's interest reported here is more than 5% of the class and shows 0% for The Vanguard Group in this amendment.

Who signed the Schedule 13G/A for Vanguard on the AHCO filing?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/26/2026.

Does this amendment disclose cash proceeds or transactions for AHCO shares?

No. The amendment reports ownership figures and the reporting realignment; it does not disclose any cash proceeds, purchases, or sales tied to AdaptHealth common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/26/2026 - 03:11 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

AdaptHealth Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AdaptHealth Corp
(b)	Address of issuer's principal executive offices: 220 West Germantown Pike, Suite 250, Plymouth Meeting, PA, 19462
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/26/2026